VOICED : AstraZeneca anuncia pausa en ensayos clínicos de su vacuna contra covid-19

AstraZeneca has paused its COVID-19 vaccine trials due to an unexplained illness in a participant. The company is conducting a routine safety review to ensure trial integrity. The vaccine, developed in partnership with Oxford University, is in Phase III trials and has been tested in multiple countries. It uses a weakened adenovirus to trigger an immune response against the coronavirus.

Why did AstraZeneca pause its COVID-19 vaccine trials?

• Because of an unexplained illness in a participant

• Due to a lack of volunteers

• The vaccine was found to be ineffective

• The trials were completed

Which university is AstraZeneca collaborating with for the COVID-19 vaccine?

• University of Oxford

• University of Cambridge

• Stanford University

• Harvard University

In which countries has AstraZeneca's vaccine been tested?

• United States, Canada, Mexico

• United Kingdom, Brazil, South Africa, United States

• India, China, Japan

• Australia, New Zealand, Singapore

What type of virus is used in AstraZeneca's vaccine to trigger an immune response?

• A flu virus

• A bacterial strain

• A weakened adenovirus

• A live coronavirus

What does the protein produced by the vaccine do?

• It causes the coronavirus to mutate

• It helps the immune system recognize and fight the coronavirus

• It destroys the coronavirus directly

• It prevents the coronavirus from entering the body